DCAF11-dependent molecular glue degrader activated by glutathionylation
A new platform leveraging DCAF11-dependent molecular glue degraders offers a novel method to destroy disease-causing proteins through glutathionylation.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 3.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
Source diversity sample: Bioengineer.org · Technology Networks · Drug Target Review · Medical Daily · Nature.
How this dossier is built: methodology · AI policy · corrections.
Where it stands
Researchers at Dana-Farber have developed a platform to identify molecular glues that destroy proteins rather than blocking them, as detailed in Nature. This technology specifically utilizes DCAF11-dependent molecular glue degraders that are activated by glutathionylation. Reporting from Bioengineer.org, Technology Networks, Drug Target Review, and Medical Daily expands on the platform's utility as a search engine for drug development.
These outlets emphasize the broader potential for E3 ligase targeting in cancer research and the discovery of metabolically activated molecular glue activity. The findings suggest the ability to tune molecular glue activity through a screen, providing a mechanism for selective protein degradation. There are no contradictions across the provided coverage.
The current state is marked by the formal documentation of the DCAF11-dependent mechanism and the established search engine platform for future drug candidates.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 58m ago.
Coverage (5)
- Dana-Farber team develops degrader platform, discovers first metabolically activated molecular glue Bioengineer.org · 2d ago
- Protein Degradation Screen Reveals Tunable Molecular Glue Activity Technology Networks · 2d ago
- New molecular glue platform broadens E3 ligase targeting for cancer drug development Drug Target Review · 2d ago
- Dana-Farber Builds a Search Engine for Drugs That Destroy Proteins Instead of Blocking Them Medical Daily · 2d ago
- DCAF11-dependent molecular glue degrader activated by glutathionylation Nature · 2d ago
Answered
What mechanism activates the molecular glue described?
The DCAF11-dependent molecular glue degrader is activated by glutathionylation.
What is the primary function of the platform developed by Dana-Farber?
The platform is designed to identify drugs that destroy specific proteins rather than simply blocking their function.
How does this research impact cancer drug development?
It expands the options for E3 ligase targeting, providing a new method for protein degradation.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Experimental Cancer Drug Force-Feeds Tumors Sugar Until They Choke
A new experimental cancer drug exploits tumors' sugar addiction to starve them out.
A compendium of next-generation patient-derived models for diverse cancers
Researchers have created a vast library of next-generation cancer models, accelerating drug development and personalized medicine.
Cancer-fighting chewing gum cuts HPV levels by up to 93%
A new chewing gum reduces HPV levels by up to 93%, sparking interest in its potential to fight cancer.
A common sugar may help cancer cells break free and spread
A new study links a common dietary sugar to the spread of ovarian cancer.
Cancer-fighting antibodies with a one-two punch take aim at tumours
Engineered bispecific antibodies are targeting B-cell lymphoma by simultaneously engaging tumor cells and activating macrophages to destroy them.
In world first, Israeli scientists find active ingredient in Viagra may stop cancer spread
Scientists in Israel have identified that the active ingredient in Viagra may possess the capability to hinder the spread of cancer.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.